{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:18:26Z","timestamp":1782523106272,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.dsx.2018.04.030","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T12:35:39Z","timestamp":1524227739000},"page":"823-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic syndrome marks early risk for cognitive decline with APOE4 gene variation: A case study"],"prefix":"10.1016","volume":"12","author":[{"given":"Dawson","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J.","family":"Gibas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2018.04.030_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/srep26119","article-title":"ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing A\u03b2 impairment of insulin signaling in an Alzheimer\u2019s disease mouse model","volume":"6","author":"Chan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dsx.2018.04.030_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2017.09.004","article-title":"The starving brain: overfed meets undernourished in the pathology of mild cognitive impairment (MCI) and Alzheimers disease (AD)","volume":"110","author":"Gibas","year":"2017","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.dsx.2018.04.030_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.dsx.2018.04.030_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2015.11.018","article-title":"Ketones block amyloid entry and improve cognition in an Alzheimers model","volume":"39","author":"Yin","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.1016\/j.dsx.2018.04.030_bib0025","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.dsx.2018.04.030_bib0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.dsx.2018.04.030_bib0035","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2013associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.dsx.2018.04.030_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/srep13842","article-title":"Differential interaction of apolipoprotein-e isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice","volume":"5","author":"Chan","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.dsx.2018.04.030_bib0045","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"Felice","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.dsx.2018.04.030_bib0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2014.08.005","article-title":"More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration","volume":"83","author":"Lane-Donovan","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.dsx.2018.04.030_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia","volume":"66","author":"Craft","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.dsx.2018.04.030_bib0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2000.tb06371.x","article-title":"Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimers disease differ according to apolipoprotein-e genotype","volume":"903","author":"Craft","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.dsx.2018.04.030_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2017.03.022","article-title":"Induced and controlled dietary ketosis as a regulator of obesity and metabolic syndrome pathologies","volume":"11","author":"Gibas","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:05:40Z","timestamp":1761728740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1871402118301152"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.04.030","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome marks early risk for cognitive decline with APOE4 gene variation: A case study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}